Ingalls & Snyder’s CAS Medical Systems CASM Stock Holding History
Bought
Maintained
Sold
Ingalls & Snyder's CASM Position: Q2 2019 in Review
Ingalls & Snyder sold out of CAS Medical Systems (CASM) in Q2 2019, closing a stake of 293,336 shares — an estimated $713K sold.
Ingalls & Snyder first reported a position in CASM in Q3 2018 and held it in 3 quarters. The position peaked at $1.14M in Q3 2018. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.
- Ingalls & Snyder reported no remaining CAS Medical Systems position as of Q2 2019 after selling out during the quarter.
- Ingalls & Snyder sold 293,336 CAS Medical Systems shares in Q2 2019, an estimated $713K.
- Ingalls & Snyder first reported a position in CAS Medical Systems in Q3 2018 and held it in 3 quarters.
- Ingalls & Snyder's CAS Medical Systems position peaked at $1.14M in Q3 2018.
- 0 funds tracked by Wall St. Rank held CAS Medical Systems as of Q2 2019.
Based on Ingalls & Snyder's 13F filing for Q2 2019, filed 11 Jul 2019.